🔎 Trials Near Me

Dachaigh › Myeloma iomaill › Ohio › Cleveland

Sgrùdaidhean clionaigeach Myeloma iomaill ann an Cleveland, OH

Tha 16 sgrùdaidhean airson Myeloma iomaill a’ lorg phàirtichean aig làraichean ann agus timcheall air Cleveland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

A’ fastadhÌre 2
  • University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06500884

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

A’ fastadhÌre 2
  • Cleveland Clinic, Cleveland
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07149857

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

A’ fastadhÌre 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Main Campus, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05552222

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 1/2
  • Research Site, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07681596

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

A’ fastadhÌre 3
  • MetroHealth Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04566328

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A’ fastadhÌre 1
  • Cleveland Clinic - Taussig Cancer Institute, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT05651932

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

A’ fastadhÌre 3
  • Research Site, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07764978

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

A’ fastadhÌre 3
  • Seidman Cancer Center-University Hospitals Cleveland Medical Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05243797

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

A’ fastadhSgrùdadh amharc
  • University Hospitals Seidman Cancer Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gearr 2026 · NCT05974150

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Cleveland Clinic, Cleveland
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

A’ fastadhÌre 1
  • Cleveland Clinic, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2025 · NCT05722418

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

A’ fastadhÌre 1/2
  • University Hospitals Cleveland, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2025 · NCT06119685

LMY-920 for Treatment of Relapsed or Refractory Myeloma

A’ fastadhÌre 1
  • University Hospitals Seidman Cancer Center, Cleveland
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Dàmh 2024 · NCT05546723

Sgrùdaidhean Myeloma iomaill ann am bailtean eile

Sgrùdaidhean eile ann an Cleveland

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.